AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 282: H457-H465, 2002; doi:10.1152/ajpheart.00546.2001
0363-6135/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rocic, P.
Right arrow Articles by Lucchesi, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rocic, P.
Right arrow Articles by Lucchesi, P. A.
Vol. 282, Issue 2, H457-H465, February 2002

Altered PYK2 phosphorylation by ANG II in hypertensive vascular smooth muscle

Petra Rocic1, Tina M. Griffin2, Chastity N. McRae1, and Pamela A. Lucchesi1

1 Department of Physiology and Biophysics, University of Alabama at Birmingham, Birmingham, Alabama 35294; and 2 Cardiovascular Institute, Stritch School of Medicine, Loyola University, Maywood, Illinois 60153

10.1152/ajpheart 00546.2001.---Vascular smooth muscle cells (VSMC) from spontaneously hypertensive rats (SHR) exhibit increased cell growth compared with normotensive Wistar-Kyoto rats (WKY). ANG II stimulates growth via Gq-protein-coupled signaling that involves changes in cytosolic intracellular Ca2+ concentration ([Ca2+]i) and activation of protein kinase C (PKC) and mitogen-activated protein kinases. This study examines the role of the proline-rich tyrosine kinase 2 (PYK2) in hypertensive VSMC. Basal PYK2 phosphorylation in SHR VSMC was increased compared with WKY (0.44 ± 0.02 vs. 0.20 ± 0.02-fold). ANG II-induced activation of PYK2 in SHR VSMC was of greater magnitude (2.2 ± 0.2-fold in SHR; 1.4 ± 0.1-fold in WKY) and occurred more rapidly (peak activation at 2 min in SHR vs. 5 min in WKY). This effect was blocked by pretreatment with the [Ca2+]i chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid or the PKC inhibitor chelerythrine. Basal and ANG II-stimulated c-Fos expression was increased in SHR versus WKY VSMC. PYK2 downregulation with antisense oligonucleotides blocked ANG II-induced c-Fos expression. Increased PYK2 activation may be altered signaling cascades that regulate cell growth in hypertensive VSMC.

mitogen-activated protein kinase; spontaneously hypertensive rats; protein kinase C; calcium; c-Fos


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Koshida, P. Rocic, S. Saito, T. Kiyooka, C. Zhang, and W. M. Chilian
Role of Focal Adhesion Kinase in Flow-Induced Dilation of Coronary Arterioles
Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2548 - 2553.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online